Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1.
Pogue
Jason M
JM
Potoski
Brian A
BA
Kaye
Keith S
KS
D058186:Acute Kidney Injury / Q000209:etiology; D000583:Amikacin / Q000009:adverse effects; D000617:Aminoglycosides / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D005839:Gentamicins / Q000009:adverse effects; D006801:Humans; D007362:Intensive Care Units; D007668:Kidney / Q000187:drug effects*; D012307:Risk Factors
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000583:Amikacin